GenSight Biologics raised €23M in a funding round in Sep 2017. The company is based in Paris, France. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €23M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
